RecruitingNot ApplicableNCT07426172

Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism.

Sponsor

Ricardo Mora

Enrollment

24 participants

Start Date

Jan 20, 2026

Study Type

INTERVENTIONAL

Conditions

Exercise Metabolic Syndrome (MetS)Hyperlactatemia Lipolysis

Summary

The purpose of this study is to investigate whether the elevated circulating lactate levels of individuals with metabolic syndrome are responsible for their reduced lipolysis and glucose tolerance. The investigators will conduct an intervention study in which blood lactate levels will be elevated via intravenous infusion of sodium lactate. State of the art metabolic assessment using stable isotopes and indirect calorimetry will be used to study alterations in fat and carbohydrate metabolism.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Saline (0.9%, sterile, for infusion) and hyperlactacidemia for people with exercise, hyperlactatemia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.